Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Colombiana de Cardiología
Print version ISSN 0120-5633
Abstract
DIAZ, James S.; MUNOZ, Edison and M. SENIOR, Juan. Natriuretic peptides in the detection of left ventricular dysfunction in a high risk population. A meta-analysis of diagnostic tests. Rev. Colomb. Cardiol. [online]. 2020, vol.27, n.6, pp.548-559. Epub Aug 02, 2021. ISSN 0120-5633. https://doi.org/10.1016/j.rccar.2019.04.013.
Introduction:
The concentration of natriuretic peptides in plasma has been proposed as a screening method for early ventricular dysfunction.
Objective:
To compare the operative characteristics of B-type natriuretic peptide (BNP) and N-terminal pro b-type natriuretic peptide (NT-proBNP) fraction in a population with risk factors.
Method:
A meta-analysis of diagnostic tests.
Results:
A search strategy was applied that found 86 references, of which 12 were selected according to the inclusion criteria. The role of BNP was evaluated in 8 of these studies, that of NT-proBNP in 3, and both tests in one of them. The cut-off points for BNP varied between 8 and 169.5 pg/mL, with a grouped sensitivity of 82.1% (95% CI; 76.7-86.4%), a grouped specificity of 69% (95%CI; 61.5-75.6%), a positive likelihood ratio (LR+) of 2.65 (95% CI; 2.17-3.23) and a negative likelihood ratio (LR() of 0.26 (95% CI; 0.21-0.32). When the data were only analysed for cut-off points below 50 pg/mL, the grouped sensitivity improved to 89.2% (95% CI; 82.6-94%), and the LR( was 0.23 (95% CI; 0.14-0.40). Only 3 studies on NT-proBNP were analysed, with cut-off points between 125 and 902 pg/mL, a grouped specificity of 97.2% (95% CI; 90.2-99.7%), a grouped sensitivity of 76.9% (95% CI; 74.5-79.1%), LR+ 3.39 (95% CI; 1.67-6.85), and LR( 0.07 (95% CI; 0.02-0.23).
Conclusion:
BNP and NT-proBNP can be useful in ruling out asymptomatic left ventricular dysfunction in patients at risk.
Keywords : Meta-analysis; Natriuretic peptides; Diagnosis; Chronic heart failure.